Product Code: 978-1-68038-034-7
Biopsy Devices Market Growth & Trends:
The global biopsy devices market size is projected to reach USD 3.64 billion by 2030, expanding at a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Introduction of technologically advanced products, leading to increasing adoption of minimally invasive surgical procedures, is the key factor driving the market.
In addition, growing investments in the oncology field by government and non-government organizations are expected to positively impact market growth. For instance, in 2022, the American Institute for Cancer Research funded more than $110 million for research to ensure a future without cancer. Moreover, the organization supports the establishment of an Advanced Research Projects Agency for Health (ARPA-H) that is focused on accelerating cancer and biomedical research translation.
The COVID-19 pandemic led to a significant drop in biopsy procedures, especially in the first half of the pandemic. This represented a temporary negative impact on the sales of biopsy devices. The major factor responsible for this moderate downfall in sales was reduced patient visits to healthcare institutes as a precautionary measure to avoid being infected with the virus.
With economies returning to normalcy and the healthcare sector going back to majorly focusing on cancer research, the market recovered at a rapid pace. The biopsy market is further expected to witness significant growth over the forecast period due to constant advancements in the field of oncology and diagnostics.
Biopsy Devices Market Report Highlights:
- Needle-based biopsy guns held the largest market share in 2023 owing to surging demand for these devices to acquire samples from soft tissues
- New product launches of vacuum-assisted biopsy devices are further expected to accelerate the demand for needle-based biopsy guns over the forecast period
- The biopsy needles segment is expected to register a significant CAGR over the forecast period. It represents lucrative growth opportunities owing to the increasing adoption of these products and the launch of advanced products
- North America dominated the market in 2023 due to the high penetration rate of technologically advanced products and the presence of key market players in the region
- The rising incidence of cancer coupled with high unmet patient needs is expected to propel the growth of the market extensively in the Asia Pacific region
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Biopsy Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Increasing prevalence of cancer
- 3.4.1.2. Growing demand for minimally invasive medical procedures
- 3.4.1.3. New product launches
- 3.4.2. Market restraint analysis
- 3.4.2.1. High cost of products
- 3.5. Biopsy Devices Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies
Chapter 4. Biopsy Devices: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Needle-based Biopsy Guns
- 4.1.2. Biopsy Guidance Systems
- 4.1.3. Biopsy Needles
- 4.1.4. Biopsy Forceps
- 4.1.5. Others
- 4.2. Product Market Share, 2022 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Biopsy Devices Market by Product Outlook
- 4.5. Market Product& Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5.1. Needle-based Biopsy Guns
- 4.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.1.2. Vacuum-assisted Biopsy (VAB) Devices
- 4.5.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.1.3. Fine Needle Aspiration Biopsy (FNAB) Devices
- 4.5.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.1.4. Core Needle Biopsy (CNB) devices
- 4.5.1.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.2. Biopsy Guidance Systems
- 4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.2.2. Manual
- 4.5.2.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.2.3. Robotic
- 4.5.2.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.3. Biopsy Needles
- 4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.3.2. Disposable
- 4.5.3.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.3.3. Reusable
- 4.5.3.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.4. Biopsy Forceps
- 4.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.4.2. General Biopsy Forceps
- 4.5.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.4.3. Hot Biopsy Forceps
- 4.5.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.5. Others
- 4.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.5.2. Brushes
- 4.5.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.5.3. Curettes
- 4.5.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.5.4. Punches
- 4.5.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 5. Biopsy Devices Market: Regional Estimates & Trend Analysis
- 5.1. Regional market share analysis, 2022 & 2030
- 5.2. Regional Market Dashboard
- 5.3. Global Regional Market Snapshot
- 5.4. Regional Market Share and Leading Players, 2022
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East and Africa
- 5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East and Africa
- 5.6. Market Product, & Forecasts and Trend Analysis, 2018 to 2030
- 5.7. North America
- 5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.7.2. U.S.
- 5.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.7.3. Canada
- 5.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.8. Europe
- 5.8.1. U.K.
- 5.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.8.2. Germany
- 5.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.8.3. France
- 5.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.8.4. Italy
- 5.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.8.5. Spain
- 5.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.8.6. Denmark
- 5.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.8.7. Sweden
- 5.8.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.8.8. Norway
- 5.8.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.9. Asia Pacific
- 5.9.1. Japan
- 5.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.9.2. India
- 5.9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.9.3. China
- 5.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.9.4. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.9.5. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.9.6. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.10. Latin America
- 5.10.1. Brazil
- 5.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.10.2. Mexico
- 5.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.10.3. Argentina
- 5.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.11. MEA
- 5.11.1. South Africa
- 5.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.11.2. Saudi Arabia
- 5.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.11.3. UAE
- 5.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 5.11.4. Kuwait
- 5.11.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
- 6.1. Recent Developments & Impact Analysis, By Key Market Participants
- 6.2. Company/Competition Categorization
- 6.2.1. Innovators
- 6.2.2. Market Leaders
- 6.2.3. Emerging Players
- 6.3. Vendor Landscape
- 6.3.1. List of key distributors and channel partners
- 6.3.2. Key customers
- 6.3.3. Key company market share analysis, 2022
- 6.3.4. Cardinal Health Inc.
- 6.3.4.1. Company overview
- 6.3.4.2. Financial performance
- 6.3.4.3. Product benchmarking
- 6.3.4.4. Strategic initiatives
- 6.3.5. Hologic, Inc.
- 6.3.5.1. Company overview
- 6.3.5.2. Financial performance
- 6.3.5.3. Product benchmarking
- 6.3.5.4. Strategic initiatives
- 6.3.6. Danaher Corporation
- 6.3.6.1. Company overview
- 6.3.6.2. Financial performance
- 6.3.6.3. Product benchmarking
- 6.3.6.4. Strategic initiatives
- 6.3.7. CONMED Corporation
- 6.3.7.1. Overview
- 6.3.7.2. Financial performance
- 6.3.7.3. Product benchmarking
- 6.3.7.4. Strategic initiatives
- 6.3.8. Cook Medical
- 6.3.8.1. Company overview
- 6.3.8.2. Financial performance
- 6.3.8.3. Product benchmarking
- 6.3.8.4. Strategic initiatives
- 6.3.9. DTR Medical
- 6.3.9.1. Company overview
- 6.3.9.2. Financial performance
- 6.3.9.3. Product benchmarking
- 6.3.9.4. Strategic initiatives
- 6.3.10. INRAD, Inc.
- 6.3.10.1. Company overview
- 6.3.10.2. Financial performance
- 6.3.10.3. Product benchmarking
- 6.3.10.4. Strategic initiatives
- 6.3.11. Devicor Medical Products Inc.
- 6.3.11.1. Company overview
- 6.3.11.2. Financial performance
- 6.3.11.3. Product benchmarking
- 6.3.11.4. Strategic initiatives
- 6.3.12. Gallini Srl
- 6.3.12.1. Company overview
- 6.3.12.2. Financial performance
- 6.3.12.3. Product benchmarking
- 6.3.12.4. Strategic initiatives
- 6.3.13. TransMed7, LLC
- 6.3.13.1. Company overview
- 6.3.13.2. Financial performance
- 6.3.13.3. Product benchmarking
- 6.3.13.4. Strategic initiatives